2 results match your criteria: "UMR 1037 Inserm-University of Toulouse III[Affiliation]"
J Steroid Biochem Mol Biol
February 2020
University Bourgogne Franche-Comté (UBFC) / Inserm, Team 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism', EA 7270, 21000 Dijon, France. Electronic address:
Chem Phys Lipids
September 2011
Cancer Research Center of Toulouse, UMR 1037 Inserm-University of Toulouse III, Toulouse, France.
Tamoxifen is one of the major drugs used for the hormonotherapy of estrogen receptor positive breast cancers. However, its therapeutic efficacy can be limited by acquired resistance and tumor recurrence can occur after several years of treatment. Tamoxifen is known as the prototypical modulator of estrogen receptors, but other targets have been identified that could account for its pharmacology.
View Article and Find Full Text PDF